Clinical Trial Update: NADPH Oxidase Polymorphisms in Obstructive Sleep Apnea Syndrome (OSAS)

View source ↗

Summary

This clinical trial update reports on NADPH oxidase polymorphisms in obstructive sleep apnea syndrome (OSAS), with the current status listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Snippet

Sponsor: Sociedad Española de Neumología y Cirugía Torácica | Conditions: Sleep Apnea Syndrome, Oxidative Stress | Status: UNKNOWN